A review with 21 references The aim is to summarize clin. research progress in selective xanthine oxidase inhibitor of febuxosta. By literature review in recent years, the literatures are classified. As a selective xanthine oxidase inhibitor of febuxostat, it has good efficacy and safety in gout.